Finally, we found that knockdown of mortalin expression via mortalin-specific siRNA reduced mortalin protein levels, and that the resultant reduction of EV secretion reversed the block on complement-mediated cytotoxicity in all three tumor cell lines. The gene discussed is HSPA9; the disease is neoplasm.